On March 30, 2020, ys ext 8600md product of Yingsheng biological inductively coupled plasma mass spectrometer obtained the medical device registration certificate issued by Shandong Provincial Drug Administration and was officially approved for listing Ys ext 8600md inductively coupled plasma mass spectrometer is an industry gold standard for the determination of trace and trace elements due to its unique ease of use, high-efficiency analysis efficiency and accuracy of qualitative data It is e
On March 25, 2020, the "fourth excellent list of medical and health investment " sponsored by Haoyue capital was officially released In the selection of this Zhuoyue list, Yingsheng biology won the award of the best IVD and precision medical enterprise of the year
In February 2020, the water-soluble vitamin detection kit (ultra high performance liquid chromatography tandem mass spectrometry) (VB1, VB2, VB3, VB5, VB6, vb7, vb9, VB12, VC) and fat soluble vitamin detection kit (ultra high performance liquid chromatography tandem mass spectrometry) (VA, VD2, VD3, VE, VK) independently developed by Shandong Yingsheng Biotechnology Co , Ltd passed the drug supervision and management of Shandong Province With the approval of the Bureau, it obtained the national
On January 31, the new coronavirus 2019-ncov nucleic acid detection kit (fluorescence PCR) developed by Shandong Yingsheng Biotechnology Co , Ltd passed all the items inspection of Shandong medical device product quality inspection center, passed the inspection, and entered the fast approval channel of the State Food and drug administration, which is also the first batch of new coronavirus detection in Shandong Province after Shandong aikewei Biotechnology Co , Ltd Testing products
On December 16th, the Precision Medical Assistance Health Industry Development Forum hosted by Yingsheng Bio was successfully held at the Boao International Conference Center in Hainan Yingsheng Bio has signed an international strategic cooperation agreement wi
Yingsheng Bio joins hands with Thermo Fisher to promote the industrialization of mass spectrometry
(health care) valuation bubble gradually squeezed out, the market is returning to reason "Asked about the biggest change in China& 39;s healthcare venture capital in recent years, many investors mentioned this They believe that after the boom of investment an
On April 8, 2021, the 3rd World Health Expo opened at Wuhan International Expo Center With the theme of "Healthy Community, Technology Creates the Future ", the main venue set up 12 professional exhibition areas including international healthcare, medi
March 26th, 2021, the "Fifth Medical and Health Investment Bonus List " sponsored by Haoyue Capital was officially announced, and Yingsheng Biology was successfully selected as the "Best Enterprise in IVD and Precision Medicine of the Year "